TABLE OF CONTENTS
Volume 43, Issue 6 (March (2) 2009)
Editorial
Follow-up into adulthood is critically important for survivors of pediatric transplant
Z E Dreyer
Bone Marrow Transplant 43: 433; doi:10.1038/bmt.2008.362
Review
Are there roles for observational database studies and structured quantification of expert opinion to answer therapy controversies in transplants?
R P Gale, M Eapen, B Logan, M-J Zhang and H M Lazarus
Bone Marrow Transplant 43: 435-446; advance online publication, February 2, 2009; doi:10.1038/bmt.2008.447
Original Articles
Cord Blood Stem Cells
Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I–II clinical trial
M L MacMillan, B R Blazar, T E DeFor and J E Wagner
Bone Marrow Transplant 43: 447-454; advance online publication, October 27, 2008; doi:10.1038/bmt.2008.348
Unrelated cord blood transplantation after myeloablative conditioning in adults with ALL
J Ooi, S Takahashi, A Tomonari, N Tsukada, T Konuma, S Kato, S Kasahara, A Sato, F Monma, F Nagamura, T Iseki, A Tojo and S Asano
Bone Marrow Transplant 43: 455-459; advance online publication, October 27, 2008; doi:10.1038/bmt.2008.347
Pediatric Transplants
Health-related quality of life in adult survivors after paediatric allo-SCT
C M Löf, J Winiarski, A Giesecke, P Ljungman and U Forinder
Bone Marrow Transplant 43: 461-468; advance online publication, October 20, 2008; doi:10.1038/bmt.2008.338
Feasibility study of preemptive withdrawal of immunosuppression based on chimerism testing in children undergoing myeloablative allogeneic transplantation for hematologic malignancies
B Horn, S Soni, S Khan, A Petrovic, N Breslin, M Cowan, G Pelle-Day, E Cooperstein and L-A Baxter-Lowe
Bone Marrow Transplant 43: 469-476; advance online publication, October 27, 2008; doi:10.1038/bmt.2008.339
Allografting
Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen
J Bolaños-Meade, L Luznik, M Muth, W H Matsui, C A Huff, B D Smith, M Y Levy, Y L Kasamon, L J Swinnen, J D Powell, R A Brodsky, R F Ambinder, R J Jones and E J Fuchs
Bone Marrow Transplant 43: 477-480; advance online publication, November 3, 2008; doi:10.1038/bmt.2008.353
Autografting
High-dose chemotherapy with autologous stem cell transplantation for multiple myeloma: what predicts the outcome? Experience from a developing country
L Kumar, J Ghosh, P Ganessan, A Gupta, R Hariprasad and V Kochupillai
Bone Marrow Transplant 43: 481-489; advance online publication, November 3, 2008; doi:10.1038/bmt.2008.343
Post-Transplant Events
Bleeding events and mortality in SCT patients: a retrospective study of hematopoietic SCT patients with organ dysfunctions due to severe sepsis or GVHD
E Holler, H J Kolb, H Greinix, D Perrotin, F Campilho, F Aversa, L Gil, J Cornelissen, L Varanese, A Schacht, A Friese and J Rustige
Bone Marrow Transplant 43: 491-497; advance online publication, December 15, 2008; doi:10.1038/bmt.2008.337
Slow platelet recovery after PBPC transplantation from unrelated donors
J Jansen, S G Hanks, L P Akard, J A Morgan, P L Nolan, M J Dugan, M I Reeves and J M Thompson
Bone Marrow Transplant 43: 499-505; advance online publication, November 10, 2008; doi:10.1038/bmt.2008.346
Letters to the Editor
Donor cell-derived sarcoidosis after allogeneic BMT
R Morita, S Hashino, K Kubota, M Onozawa, K Kahata, T Kondo, S Suzuki, Y Matsuno, M Imamura and M Asaka
Bone Marrow Transplant 43: 507-508; advance online publication, October 27, 2008; doi:10.1038/bmt.2008.340
High-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimen
M Magni, M Di Nicola, C Carlo-Stella, P Matteucci, L Devizzi, C Tarella, F Benedetti, M Martelli, C Patti, G Parvis, A Rambaldi, T Barbui and A M Gianni
Bone Marrow Transplant 43: 509-511; advance online publication, October 27, 2008; doi:10.1038/bmt.2008.349
Nitric oxide in transplantation-related thrombotic microangiopathy
J Thachil
Bone Marrow Transplant 43: 513-514; advance online publication, November 3, 2008; doi:10.1038/bmt.2008.350
Yersinia pseudotuberculosis causing abscesses in a 31-year-old patient in the post-immunosuppression period after allogeneic HSCT
F Stölzel, S Pursche, S Brückner, M Bornhäuser, G Ehninger and M Schaich
Bone Marrow Transplant 43: 515-516; advance online publication, November 3, 2008; doi:10.1038/bmt.2008.357
